1994
DOI: 10.1136/gut.35.7.909
|View full text |Cite
|
Sign up to set email alerts
|

Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha.

Abstract: Neutrophil adherence within the gastric microcirculation is thought to be a major step in the pathogenesis of gastric mucosal damage induced by indomethacin. Pentoxifylline, a methylxanthine derivative, prevents leukocyte adherence to vascular endothelium and protects organs from shock by reducing tumour necrosis factor a (TNFa) concentrations. Rats were treated with 20 mg/kg oral indomethacin, pretreated with vehicle or with four different doses of pentoxifylline intraperitoneally, and killed after three hour… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
121
0
3

Year Published

1997
1997
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 192 publications
(125 citation statements)
references
References 25 publications
1
121
0
3
Order By: Relevance
“…Although their efficiency in most cases, NSAIDs were proven to induce the secretion of TNF-a especially when they are used chronically. Overproduction of TNF-a believes to play a key role in the onset and progression of various pathologies such as disseminated intravascular coagulation and death in septic choc and cerebral malaria (Medana et al 1997;Murphy et al 1998) and a range of inflammatory diseases including asthma (Bj€ ornsdottir & Cypcar 1999), dermatitis, inflammatory bowel disease, cystic fibrosis, rheumatoid arthritis and multiples sclerosis (Sekut & Connolly 1996); in addition, TNF-a has been shown to be a crucial mediator of NSAIDs-induced gastric mucosal injury (Santucci et al 1994). In spite of enormous efforts, the only available drugs to inhibit TNFa activity, in clinics, are proteins (Etanercept, Infliximab, Adalimumab and Anakinra) that display adverse effects such as aplastic anaemia, pancytopenia, vasculitis, demyelination and congestive heart failure (Desai & Furst 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Although their efficiency in most cases, NSAIDs were proven to induce the secretion of TNF-a especially when they are used chronically. Overproduction of TNF-a believes to play a key role in the onset and progression of various pathologies such as disseminated intravascular coagulation and death in septic choc and cerebral malaria (Medana et al 1997;Murphy et al 1998) and a range of inflammatory diseases including asthma (Bj€ ornsdottir & Cypcar 1999), dermatitis, inflammatory bowel disease, cystic fibrosis, rheumatoid arthritis and multiples sclerosis (Sekut & Connolly 1996); in addition, TNF-a has been shown to be a crucial mediator of NSAIDs-induced gastric mucosal injury (Santucci et al 1994). In spite of enormous efforts, the only available drugs to inhibit TNFa activity, in clinics, are proteins (Etanercept, Infliximab, Adalimumab and Anakinra) that display adverse effects such as aplastic anaemia, pancytopenia, vasculitis, demyelination and congestive heart failure (Desai & Furst 2006).…”
Section: Introductionmentioning
confidence: 99%
“…4,5 Previous reports have studied a range of doses of pentoxifylline with signi®cant effects occurring with 100 mg/kg and higher concentrations up to 200 mg/kg. 8 Following treatment with pentoxifylline (200 mg/kg) rats showed signs of toxicity including lethargy and hypersalivation, thus for our study where treatment with pentoxifylline was of a more chronic nature we chose a dose of 100 mg/kg which caused no signs of toxicity. In preliminary studies animals were sacri®ced at 24 h following TNBS to verify the presence of ulcers and in¯ammation.…”
Section: Methodsmentioning
confidence: 99%
“…Myeloperoxidase released into the supernatant (250 lL) was assayed spectrophotometrically using TMB as substrate. 25 The sample was both incubated and assayed in triplicate. Myeloperoxidase secreted during incubation was expressed as a percentage of total myeloperoxidase present in PMN at the beginning of the incubation minus the enzyme secreted prior to starting incubation.…”
Section: Myeloperoxidase Releasementioning
confidence: 99%